At a glance
ClinicalIndex Comparison RecordN/ACompleted· 66 enrolled
Drug / intervention
High dose Human Lactoferrin +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-blind, Controlled, Parallel-arm Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Function in Healthy Adults
Midwest Center for Metabolic and Cardiovascular Research·interventional·Posted Aug 25, 2023·Updated Jun 11, 2025
In Brief
A clinical study evaluating High dose Human Lactoferrin, Low dose Human Lactoferrin, and 1 other intervention for Immune Health. Completed, enrolled 66 participants across 2 sites.
Detailed Summary
The purpose of this study is to evaluate the impact of 28-day supplementation with high-dose human recombinant lactoferrin, low-dose human recombinant lactoferrin, and an active control product formulated with bovine lactoferrin on indicators of immunity in healthy males and females.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsImmune Health
CountriesUnited States
CollaboratorsHelaina Inc.
Timeline
N/ACompletedFinished
202420252026
First PostedAug 2023
Enrollment StartSep 2023
Primary CompletionDec 2023
TodayJul 2026
First PostedAug 25, 2023
Enrollment StartSep 6, 2023
Primary CompletionDec 27, 2023
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 2.9 years ago
Interventions
High dose Human Lactoferrindietary
Dietary Supplement and Food Ingredient
Low dose Human Lactoferrindietary
Dietary Supplement and Food Ingredient
Active Control Bovine Lactoferrindietary
Dietary Supplement and Food Ingredient